Champions Oncology Inc Stock
Your prediction
Champions Oncology Inc Stock
We can see a decrease in the price for Champions Oncology Inc. Compared to yesterday it has lost -€0.120 (-2.600%).
Pros and Cons of Champions Oncology Inc in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Champions Oncology Inc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Champions Oncology Inc | -2.600% | -3.433% | 0.897% | 1.810% | -6.639% | -50.820% | - |
Ardelyx Inc. | 6.810% | -0.366% | -11.361% | 47.951% | 3.668% | -1.770% | - |
Salarius Pharmaceuticals Inc. | -2.830% | -3.738% | -2.830% | -71.389% | -25.766% | -98.474% | -99.994% |
Brainstorm Cell | -30.000% | -29.447% | -33.143% | -87.283% | 51.293% | -87.897% | - |
News
3 Dividend Champions with room for dividend growth
The World Series champion Texas Rangers recently paid nice dividends for sports bettors. For stock investors, there's a different, more predictable group of dividend payers worth betting on — the
Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification
HACKENSACK, NJ / ACCESSWIRE / November 2, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology